Austin Private Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.24M Buy
1,152
+52
+5% +$49.7K 0.09% 97
2025
Q3
$840K Sell
1,100
-139
-11% -$103K 0.06% 122
2025
Q2
$966K Buy
1,239
+181
+17% +$141K 0.08% 113
2025
Q1
$874K Buy
1,058
+183
+21% +$152K 0.08% 112
2024
Q4
$676K Buy
875
+158
+22% +$131K 0.06% 121
2024
Q3
$635K Buy
717
+21
+3% +$18.9K 0.06% 120
2024
Q2
$630K Sell
696
-95
-12% -$76K 0.07% 103
2024
Q1
$614K Buy
791
+174
+28% +$124K 0.07% 101
2023
Q4
$360K Buy
617
+71
+13% +$41.4K 0.05% 130
2023
Q3
$293K Buy
546
+28
+5% +$14.4K 0.04% 129
2023
Q2
$243K Buy
+518
New +$217K 0.04% 142

Other funds holding LLY

Austin Private Wealth's LLY Position: Q4 2025 in Review

Austin Private Wealth increased its Eli Lilly (LLY) stake by 4.7% in Q4 2025, buying an estimated $49.7K and bringing the position to 1,152 shares worth $1.24M. The position accounts for 0.09% of the portfolio, ranked #97.

Austin Private Wealth first reported a position in LLY in Q2 2023 and has held it in 11 quarters since. 4,429 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Austin Private Wealth held 1,152 shares of Eli Lilly worth $1.24M as of Q4 2025.
  • Austin Private Wealth bought 52 Eli Lilly shares in Q4 2025, an estimated $49.7K.
  • Eli Lilly made up 0.09% of Austin Private Wealth's portfolio in Q4 2025, its #97 holding.
  • Austin Private Wealth first reported a position in Eli Lilly in Q2 2023 and has held it in 11 quarters since.
  • 4,429 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Austin Private Wealth's 13F filing for Q4 2025, filed 20 Jan 2026.